![Mel Hayes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mr. Mel Hayes was previously employed as an Executive Vice President-Patient Experience by Fulcrum Therapeutics, Inc., a Global Vice President-Hemophilia by Baxalta, Inc., a Vice President-Hemophilia by Bioverativ, Inc., a VP-Rare Blood Disorders & Global Head-Commercial by Genzyme Corp., a VP-Rare Blood Disorders & Global Head-Commercial by Sanofi Ventures LLC, and a Global VP & Head-Global Marketing by Shire, Inc. He received his undergraduate degree from Southern Methodist University and an MBA from Columbia Business School.
| Unternehmen | Position | Ende |
|---|---|---|
| BAXALTA INC | Corporate Officer/Principal | - |
Shire, Inc.
 Shire, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Vertrieb & Marketing | - |
| BIOVERATIV INC | Corporate Officer/Principal | - |
Sanofi Ventures
 Sanofi Ventures Investment ManagersFinance Sanofi Ventures invests in companies located in the United States. The firm targets companies operating in the fields of biotech and digital health sectors. It provides financing for seed and early stage capital requirements. It acts as lead investor and also takes a seat on board of directors. | Corporate Officer/Principal | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 8 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Southern Methodist University
 Southern Methodist University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi Ventures
Sanofi Ventures Investment ManagersFinance Sanofi Ventures invests in companies located in the United States. The firm targets companies operating in the fields of biotech and digital health sectors. It provides financing for seed and early stage capital requirements. It acts as lead investor and also takes a seat on board of directors. | Finance |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fulcrum Therapeutics, Inc.
 Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
Shire, Inc.
Shire, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
